about
The relationship between mercury and autism: A comprehensive review and discussionRelevance of Neuroinflammation and Encephalitis in AutismAn evaluation of the role and treatment of elevated male hormones in autism spectrum disordersEvidence of parallels between mercury intoxication and the brain pathology in autismNew science challenges old notion that mercury dental amalgam is safeThimerosal: clinical, epidemiologic and biochemical studiesSensory correlations in autismBarriers to implementation of a computerized decision support system for depression: an observational report on lessons learned in "real world" clinical settingsA longitudinal ecological study of household firearm ownership and firearm-related deaths in the United States from 1999 through 2014: A specific focus on gender, race, and geographic variables.Abnormal Brain Connectivity Spectrum Disorders Following Thimerosal Administration: A Prospective Longitudinal Case-Control Assessment of Medical Records in the Vaccine Safety Datalink.Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.Prospective trial of equine-assisted activities in autism spectrum disorder.Efficacy of porcine secretin in children with autism and pervasive developmental disorder.A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disordersA Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of AutismThimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalinkSulfhydryl-reactive metals in autism.A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity.Biomarkers of environmental toxicity and susceptibility in autism.A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.The effectiveness of secretin in the management of autism.A Prospective Longitudinal Assessment of Medical Records for Diagnostic Substitution among Subjects Diagnosed with a Pervasive Developmental Disorder in the United States.A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.Hair toxic metal concentrations and autism spectrum disorder severity in young children.A prospective Cross-sectional Cohort Assessment of Health, Physical, and Behavioral Problems in Autism Spectrum Disorders.Assessing physicians' use of treatment algorithms: Project IMPACTS study design and rationale.Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of ChildhoodA clinical trial of glutathione supplementation in autism spectrum disordersProspective, blinded exploratory evaluation of the PlayWisely program in children with autism spectrum disorder.Evidence of neurodegeneration in autism spectrum disorderThimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study.Examining genotypic variation in autism spectrum disorder and its relationship to parental age and phenotype.Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism.A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins.Evaluation of regression in autism spectrum disorder based on parental reports.Are ASD and ADHD a Continuum? A Comparison of Pathophysiological Similarities Between the Disorders.Thimerosal as discrimination: vaccine disparity in the UN Minamata Convention on mercury.Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
P50
Q26740476-61E6E621-9DEC-403C-A525-21CF5F348349Q26772834-8B604CB9-F1F0-4756-87E4-BBFE798326A2Q26820611-5E8A23DA-5A59-4A04-801F-F9EF9314CCC8Q27003899-5E3DDB9B-600D-4924-9850-770DD6FBE9A3Q27006894-A27BA66B-9D7A-48C8-AC10-6C90781BB066Q28087764-16E83650-793E-474E-9CF4-1BE4C5FF229BQ28292620-C2318FA2-CA44-49E7-9211-91554AC12034Q33401687-831B8B49-4FCC-478A-B4FF-2796492322D5Q33599676-032E6596-8E1E-4EBB-B43E-E051AFBCAD9BQ33693281-D0C8B317-EB41-4546-97D7-5908116E4F06Q33787078-BC61B597-2432-4985-91D9-624651B612CBQ34029801-9F4EECEF-51D7-47BC-B6F3-608FFEAD84A7Q34137776-AD491719-B65C-46EF-BD25-AF7170FCE0E9Q34348131-F9764576-372F-4F68-A714-F632D74F3EADQ34361783-DC8A76F3-BFDC-4E4F-A9F0-D74DAE461B1BQ34432373-E9EEEEDB-B0CD-4147-AC74-3389AF33513CQ34609274-52064994-C413-40F2-8D6E-F39CA1FF5D72Q34609811-91E725F8-3CD0-4CE3-AA85-495DB8089E27Q34837538-E41A0DFE-C621-4711-A202-4082DDA986D6Q34978632-28E705BA-94D4-46BA-AB03-3A9740DFAA76Q35680610-E148B47A-B424-4E9E-A170-5286F94A3FC5Q36146224-06D2B769-1B1B-4C9E-9612-6CA33CD52C88Q36516455-097EF9FF-8500-4C42-B047-1C2FF27C3F6CQ36538671-C038ADCA-04D3-43DE-9B56-A124895313FFQ36594280-08909C5A-E8A3-43BC-B4D9-C5FE56C96CEEQ36602237-318E8ECF-743B-4FA0-BB40-0B910691D4DAQ36735514-B75798A3-ED98-4785-8A6E-DF0BB53127BCQ36771431-C4C312B9-309C-4E08-9FFA-4C5AFA7C1409Q36895982-D0E59D93-7411-4C98-A151-F435D2A63643Q37115878-C76741A2-D1AB-4FC4-A473-3C38723C34F6Q37128178-D59815B1-6247-4A4E-B350-B4810B3C328BQ37143227-80D43088-83BD-49DC-8D5D-C9A75753D44FQ37170244-7E3C1098-8D43-4F89-AA6F-C3C43C46A848Q37175425-66DD0EF2-784D-40DA-A060-A06E35D7DF06Q37425919-7587736D-7E3B-4F5E-8F61-DFE276FEE54BQ37503349-388DC2F6-5306-4727-8259-F770DF1CB0D2Q37610549-3C7B996C-C430-4C9B-98F9-6D4264D68E41Q38052887-05F42C22-90AA-4853-959B-DEC7FDF70159Q38237674-40A972C1-E89E-403A-90B2-E6DD28E20AF0Q38324771-FE247D8C-8090-4774-98CA-55B14467E7A3
P50
description
Amerikaans onderzoekster
@nl
amerikansk forsker
@nb
researcher
@en
name
Janet K. Kern
@en
Janet K. Kern
@es
Janet K. Kern
@nb
Janet K. Kern
@nl
جانيت كي. كيرن
@ar
type
label
Janet K. Kern
@en
Janet K. Kern
@es
Janet K. Kern
@nb
Janet K. Kern
@nl
جانيت كي. كيرن
@ar
altLabel
Janet K Kern
@en
Janet Kern
@en
Janet Kern
@nb
Janet Kinnear Kern
@en
Janet Kinnear Kern
@nb
prefLabel
Janet K. Kern
@en
Janet K. Kern
@es
Janet K. Kern
@nb
Janet K. Kern
@nl
جانيت كي. كيرن
@ar
P106
P21
P214
92151776825418012554
P31
P734
P735
P7859
viaf-92151776825418012554